ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0171490505199911 0.06210375
NSC 639981 Null 0.0171490505199911 0.11821885
NSC 641240 Null 0.0171490505199911 0.19570869
NSC 666113 Null 0.0171490505199911 0.31696564
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 0.0171490505199911 0.24397636
NSC 704556 Null 0.0171490505199911 0.1885897
NSC 716678 Null 0.0171490505199911 0.15183125
NSC 756833 Null 0.0171490505199911 0.048824457
NSC 746513 5-Triazol-2-yl-methyl-2-[2?,(2??-chlorophenyl)-thiazolidin-4?-one-3?-yl]-1,3,4-oxadiazole 0.0171490505199913 0.10886009
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0177048892222172 0.16535602
Total:99  Current:47    [First] [Prev] [Next] [Last]